General Information
Product name
Pregabalin Capsules, 25 mg, 50 mg, 75 mg,
1.2.1 Relevant identified uses
Management of neuropathic pain associated with diabetic peripheral neuropathy Hetero Labs Limited, Unit-III
Manufacturer Name
Plot No. 22-110
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361d
Hazard statements
Code
Statements
H361d
Suspected of damaging the unborn child.
Section 2
2.1 Classification of the substance or mixture
Reproductive Toxicity: Category 2
Signal word
Warning
Hazard statements
H361d - Suspected of damaging the unborn child P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P308 + P313 - IF exposed or concerned: Get
Precautionary statements
medical attention/advice P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations An Occupational Exposure Value has been
2.3 Other hazards
established for one or more of the ingredients (see Section 8). This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. Note The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.